Home›Companies›Biotech & Pharma›Dvant Pharma

Dvant Pharma, Inc.

Develops cancer drugs for patients.

Updated Nov 9, 2026·Latest SEC filing Oct 13, 2026·Suggest an edit

About Dvant Pharma

Dvant Pharma is a private company based in Superior Township, Michigan. It has reported $1,230,400 raised in one offering on Form D since October 2026. Its chief executive is Andrew Kocab.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 29, 2026Oct 13, 2026$1,230,400of $3.0M target9$136KEquity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Dvant Pharma's Form D filed Oct 13, 2026.

AK
Andrew Kocab
Chief Executive Officer and director
MN
Mukesh Nyati
Executive officer and director
VA
JA
Jim Adox
Director

Sources

  1. SECDvant Pharma, Inc. filing history
  2. CompanyDvant Pharma company page
  3. ResearchUniversity of Michigan Innovation Partnerships: Dvant Pharma